Sang­amo joins biotech mi­gra­tion to Oys­ter Point with new HQ

Join­ing the flock of biotechs head­ed to Oys­ter Point, gene ther­a­py com­pa­ny Sang­amo Ther­a­peu­tics is build­ing a new head­quar­ters and man­u­fac­tur­ing fa­cil­i­ty in the Bay Area de­vel­op­ment.

The new site will be 88,000 square-feet of space at 7000 Ma­ri­na Boule­vard. It will in­clude lab­o­ra­to­ries, work­sta­tions, col­lab­o­ra­tive space, and a large-scale man­u­fac­tur­ing fa­cil­i­ty to make Sang­amo’s ge­nom­ic ther­a­pies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER